BioHorizons, Inc., a subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world.
BioHorizons’ dental implants are clinically proven through some of the most thorough and in-depth research in the industry. The company offers ten comprehensive implant lines, covering virtually every surgical and prosthetic indication or clinician preference, and their dental implants have a 99.2% average implant success rate. BioHorizons’ implant products are treated with their proprietary Laser-Lok technology, scientifically proven to reduce bone loss compared to traditional dental implants.
InnovaHealth Partners’ predecessor firm, HealthpointCapital, invested in BioHorizons in 2006, sold a 60% stake of the company to Henry Schein, Inc. in December 2013 and its remaining ownership stake in January 2018. Mortimer Berkowitz III served as Chairman of BioHorizons prior to its sale to Henry Schein.